KYAH01-2019-121

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameKYAH01-2019-121
Drug Alias Namecap dependent endonuclease inhibitor (Kunming Pharmaceutical)CEN inhibitor (Kunming Pharmaceutical)KYAH01-2019-121
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndonucleases inhibitors
TargetsEndonucleases
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesKpc Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKpc Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A